David Erritzøe
Imperial College London
2 papers in the Anchorcite directory, published between 2016 and 2021, cited 3,119 times in total.
ORCID profileResearch topics
- Treatment of Major Depression · 2 papers
- Psychedelics and Drug Studies · 2 papers
- Psychotherapy Techniques and Applications · 1 paper
- Tryptophan and brain disorders · 1 paper
Frequent co-authors
- Robin Lester Carhart-Harris · 2 papers
- David Nutt · 2 papers
- Mark Bolstridge · 1 paper
- James Rucker · 1 paper
- Camilla Day · 1 paper
- Mendel Kaelen · 1 paper
- Michael Bloomfield · 1 paper
- Ben Forbes · 1 paper
Papers
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyThe Lancet Psychiatry · 2016 · 1,643 citations
BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results.…
- Trial of Psilocybin versus Escitalopram for DepressionNew England Journal of Medicine · 2021 · 1,476 citations
BACKGROUND: Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking. METHODS: In a phase 2, double-blind, randomized, controlled trial involving patients with long-standing, moderate-to-severe major depressive disorder, we compared psilocybin with escitalopram,…
Metadata from OpenAlex (CC0).